Heart disease is the leading cause of death in the world. It accounts for more than 17 million deaths a year and that figure is rising.
George Clinical’s scientific leadership is primarily focussed on developing new strategies for the prevention of heart diseases by targeting their primary risk factors such as high blood pressure and cholesterol, through drug and device interventions.
The depth of George Clinical’s therapeutic expertise places us as global experts in designing and implementing studies measuring cardiovascular co-morbidities and outcomes to the highest scientific standard.
George Clinical’s scientific leadership have a formidable track record of providing evidence to effect real change in practice and policy so that our research translates into clinical practice and government policy.
Our clinical trial services in cardiovascular health include:
- Program / Protocol design
- Scientific Leadership
- Project Management
- Clinical Monitoring
- Regulatory Services
- Medical Monitoring
- Safety Services including Endpoint Adjudication and DSMBs
- Data Management
- Health Economics
George Clinical’s global cardiovascular investigator networks are substantial. Our expertise and capacity to engage with Asian investigator networks, place us as one of the leading cardiovascular contract research organisations operating in this therapeutic area.